SHAWN HIRSCH to Humans
This is a "connection" page, showing publications SHAWN HIRSCH has written about Humans.
Connection Strength
0.029
-
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo-controlled crossover laboratory study. Am J Addict. 2025 Jan; 34(1):7-14.
Score: 0.006
-
A randomized trial of safety and pharmacodynamic interactions between a selective glucocorticoid receptor antagonist, PT150, and ethanol in healthy volunteers. Sci Rep. 2021 05 10; 11(1):9876.
Score: 0.005
-
Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial. J Perinatol. 2021 08; 41(8):2072-2087.
Score: 0.005
-
Health Services Utilization, Health Care Costs, and Diagnoses by Mild Traumatic Brain Injury Exposure: A Chronic Effects of Neurotrauma Consortium Study. Arch Phys Med Rehabil. 2020 10; 101(10):1720-1730.
Score: 0.005
-
Understanding the impact of mild traumatic brain injury on veteran service-connected disability: results from Chronic Effects of Neurotrauma Consortium. Brain Inj. 2018; 32(10):1178-1187.
Score: 0.004
-
Chronic Effects of Neurotrauma Consortium (CENC) multicentre study interim analysis: Differences between participants with positive versus negative mild TBI histories. Brain Inj. 2018; 32(9):1079-1089.
Score: 0.004